These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 20441117)

  • 21. Perceived barriers to provision of medication therapy management services (MTMS) and the likelihood of a pharmacist to work in a pharmacy that provides MTMS.
    Blake KB; Madhavan SS
    Ann Pharmacother; 2010 Mar; 44(3):424-31. PubMed ID: 20179254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Institutional support of continuing education as a fringe benefit for hospital pharmacists.
    Herbert WJ; Mergener MA; De Muth JE
    Hosp Pharm; 1982 Aug; 17(8):412-3, 417-8. PubMed ID: 10256698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opinions of pharmacy, medicine, and pharmaceutical industry leaders about hypothetical therapeutic-interchange legislation.
    Segal R; Grines LL; Pathak DS
    Am J Hosp Pharm; 1988 Mar; 45(3):570-7. PubMed ID: 3369459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical services provided by staff pharmacists in a community hospital.
    Garrelts JC; Smith DF
    Am J Hosp Pharm; 1990 Sep; 47(9):2011-5. PubMed ID: 2244945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Attitudes and policies about continuing education among Wisconsin hospital pharmacy directors.
    LeRoy ML; De Muth JE
    Am J Hosp Pharm; 1987 Jun; 44(6):1381-5. PubMed ID: 3618616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of pharmacist participation on a medical team on costs, charges, and length of stay.
    Haig GM; Kiser LA
    Am J Hosp Pharm; 1991 Jul; 48(7):1457-62. PubMed ID: 1882873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patient awareness and concern regarding pharmaceutical manufacturer interactions with doctors.
    Edwards D; Ballantyne A
    Intern Med J; 2009 Mar; 39(3):191-6. PubMed ID: 19383067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-prescription medicines: current issues in Australian community pharmacy.
    Tan AC; Emmerton L
    Int J Pharm Pract; 2009 Aug; 17(4):207-13. PubMed ID: 20217945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of hospital and community pharmacists in pharmacovigilance.
    van Grootheest AC; de Jong-van den Berg LT
    Res Social Adm Pharm; 2005 Mar; 1(1):126-33. PubMed ID: 17138470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of continuing professional development portfolio records on pharmacy practice.
    Kostrzewski AJ; Dhillon S; Goodsman D; Taylor KM
    Int J Pharm Pract; 2009 Apr; 17(2):107-13. PubMed ID: 20214259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Perception of prescription medicine sample packs among Australian professional, government, industry, and consumer organizations, based on automated textual analysis of one-on-one interviews.
    Kyle GJ; Nissen L; Tett S
    Clin Ther; 2008 Dec; 30(12):2461-73. PubMed ID: 19167604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacists' and patients' roles in the pharmacist-patient relationship: are pharmacists and patients reading from the same relationship script?
    Worley MM; Schommer JC; Brown LM; Hadsall RS; Ranelli PL; Stratton TP; Uden DL
    Res Social Adm Pharm; 2007 Mar; 3(1):47-69. PubMed ID: 17350557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Attitudes of Australian pharmacists towards practice-based research.
    Peterson GM; Jackson SL; Fitzmaurice KD; Gee PR
    J Clin Pharm Ther; 2009 Aug; 34(4):397-405. PubMed ID: 19583672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 2006 national clinical pharmacy services survey: clinical pharmacy services, collaborative drug management, medication errors, and pharmacy technology.
    Bond CA; Raehl CL
    Pharmacotherapy; 2008 Jan; 28(1):1-13. PubMed ID: 18154468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Competency, board certification, credentialing, and specialization: who benefits?
    Gourley DR; Fitzgerald WL; Davis RL
    Am J Manag Care; 1997 May; 3(5):795-801; quiz 805-7. PubMed ID: 10169540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of a renal drug dosing service on dose adjustment in hospitalized patients with chronic kidney disease.
    Hassan Y; Al-Ramahi RJ; Aziz NA; Ghazali R
    Ann Pharmacother; 2009 Oct; 43(10):1598-605. PubMed ID: 19776297
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmaceutical industry funding of events for healthcare professionals on non-vitamin K oral anticoagulants in Australia: an observational study.
    Behdarvand B; Karanges EA; Bero L
    BMJ Open; 2019 Aug; 9(8):e030253. PubMed ID: 31434780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacist-industry relationships.
    Saavedra K; O'Connor B; Fugh-Berman A
    Int J Pharm Pract; 2017 Dec; 25(6):401-410. PubMed ID: 28097713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Professional reading habits of pharmacists attending 2 educational seminars in New York City.
    Nathan JP; Grossman S
    J Pharm Pract; 2012 Dec; 25(6):600-5. PubMed ID: 22842503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in the type and amount of spending disclosed by Australian pharmaceutical companies: an observational study.
    Parker L; Karanges EA; Bero L
    BMJ Open; 2019 Feb; 9(2):e024928. PubMed ID: 30782921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.